Skip to content

Clinical trials

Terminated Neurocognitive Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neurocognitive Disorders Status: Terminated Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20111
20122
20131
20141
20151
20174
20182
20193
20212
20231
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated22

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
UMC Utrecht2
Alzheimer's Disease Expert Lab (ADEL), Inc.1
Alzheon Inc.1
Florida International University1
Genentech, Inc.1
Hoffmann-La Roche1
Inmune Bio, Inc.1
Luzerner Kantonsspital1
Medical College of Wisconsin1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neurocognitive Disorders22
Alzheimer Disease9
Brain Diseases9
Dementia9
Mental Disorders8
Nervous System Diseases8
Neurodegenerative Diseases7
Central Nervous System Diseases6
Tauopathies6
Cognitive Dysfunction3

Trials

Showing 76 to 22 of 22. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.